• 🌎 Worldwide
    • πŸ‡ΊπŸ‡Έ U.S.
    • πŸ‡¨πŸ‡¦ Canada
    • πŸ‡¬πŸ‡§ United Kingdom
    • 🌏 Asia
    • 🌍 Europe
    • 🌎 Latin America
    • 🌏 Oceania and Australasia
The Daily Marijuana Observer
SUBSCRIBE
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
  • Home
  • Latest
  • Business
  • Investments
  • Law
  • People
  • Health
  • Databases
No Result
View All Result
The Daily Marijuana Observer
No Result
View All Result
Home PRO

PRO: Cantor Fitzgerald Analyst Reiterates Buy Rating on Cara Therapeutics with a High Price Target

Steven Lachard by Steven Lachard
April 15, 2019
in Analyst Action, Investments, Marijuana Stocks, PRO, Trading
Cantor Fitzgerald Analyst Research Coverage - Cannabis Stocks

Lucy Hale attends the Annual Charity Day hosted by Cantor Fitzgerald, BGC and GFI at Cantor Fitzgerald on September 11, 2018 in New York City. (Photo by Noam Galai/Getty Images for Cantor Fitzgerald)

133
SHARES
ShareShare

In a recently released analyst research report, Cantor Fitzgerald Senior Research Analyst, Charles C. Duncan, reiterated his buy rating on shares of Cara Therapeutics, Inc. (NASDAQ:CARA) with a price target that suggests some noteworthy upside to come.

This comes just a few days after Stifel Nicolaus’ Senior Equity Analyst covering Specialty Pharmaceuticals,Β Annabel Samimy, reiterated her buy rating on shares of CARA with a similar price target.

Charles C. Duncan’s price target of $27.00 USD per share implies a potential upside of approximately 44.15% based on the last traded price of $18.73 USD per share on the NASDAQ.

According to Markets.co, “We reiterate our Overweight rating and 12-month price target of $27 on Cara Therapeutics. We recently hosted a KOL call with a physician who has expertise in chronic kidney disease associated pruritus (CKD-aP). As a result of this recent due diligence, we have enhanced conviction about the P3 KALM-1/-2 study readouts and potential for KORSUVA (CR845/difelikefalin) to usher-in a paradigm shift and a new SoC for this high-burden symptom of disease. Our KOL chaired the DSMB for the KORSUVA Phase 2 study and is an investigator for the P3 KALM-1 study, although we explicitly did not address his P3 patient experience.”

Be sure toΒ subscribe to updates here so you never miss an important development.

Share this:

  • Click to email this to a friend (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Reddit (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on Tumblr (Opens in new window)
  • Click to share on Pocket (Opens in new window)
Tags: biotechCantor FitzgeraldCara Therapeutics Inc.Charles DuncanNASDAQ:CARA

Get Real-Time Updates from MJobserver.com

Unsubscribe
Steven Lachard

Steven Lachard

Steven Lachard is a staff writer for MJobserver.com with a particular focus on marijuana stocks. Beyond MJobserver.com, Steven's pot stock insights have been featured on TalkMarkets.com and more.

Related Posts

Cannabis Investor Conference News
Briefs

Skye Bioscience to Present at Upcoming Investment Conferences in April

April 15, 2021
Cannabis Stock News
Investments

YCBD Stock Outpaces Cantor Fitzgerald Analyst Price Target

February 4, 2021
Epidiolex from GW Pharmaceuticals
Investments

Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader

February 3, 2021
Jushi Holdings Cannabis Stock News
Investments

Cantor Fitzgerald Raises Price Target on Jushi Holdings

February 2, 2021
Epidiolex from GW Pharmaceuticals
Investments

Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy Community

October 21, 2020
Epidiolex from GW Pharmaceuticals
Executives

GW Pharmaceuticals Announces the Appointment of David Gryska to its Board of Directors

September 10, 2020
Load More
Next Post
1933 Industries Teams Up with Hip-Hop Artist Kurupt for the 4/20 Launch of 'Gotti's Gold' Brand of Cannabis Products

1933 Industries Teams Up with Hip-Hop Artist Kurupt for the 4/20 Launch of 'Gotti's Gold' Brand of Cannabis Products

Leave a Comment! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

🚨 Subscribe to Stock Alerts

Get Live Updates on Breaking News

Subscribe Now

βœ‰οΈ Subscribe to Our Newsletter!

* indicates required

πŸ”Ž Search Marijuana Stocks

πŸ“° Recent News

  • Is Medterra a Publicly-Traded Company?
  • Skye Bioscience to Present at Upcoming Investment Conferences in April
  • What Is Hash And Why Is It Making A Comeback?
  • Verano Upgraded to OTCQX Best Market
  • Green Thumb Industries Announces Launch of Leading Cannabis-Infused Social Tonic Brand Cann in Illinois Ahead of 4/20 Cannabis Holiday
Facebook Twitter Instagram LinkedIn Youtube

Cannabis News by Region

  • πŸ‡ΊπŸ‡Έ United States
  • πŸ‡¨πŸ‡¦ Canada
  • πŸ‡¬πŸ‡§ United Kingdom
  • 🌏 Asia
  • 🌍 Europe
  • 🌎 Latin America
  • 🌏 Oceania and Australasia

Cannabis Tools & Resources

  • πŸ“… Calendar
  • πŸ“Š Databases
  • πŸ“‡ Directories
  • πŸ”” RSS Feeds
  • πŸ“Ί Videos

Find Cannabis Business Services

  • βš–οΈ Attorneys & Law Firms
  • πŸ“Š Accountants & Accounting Firms
  • πŸ’‘ Consultants & Consulting Firms
  • πŸ“² Marketing Agencies & Firms

The Daily Marijuana Observer

  • Subscribe
  • About MJobserver.com
  • Affiliate Marketing Disclosure
  • Legal Disclaimer
  • Privacy Policy
  • Contact Us

Advertise with Us

  • πŸ‘€ Advertise
  • πŸ“£ DMO Newswire
  • πŸ“‡ List in Our Databases

Β© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerβ„’ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

No Result
View All Result
  • Home
  • Latest
  • πŸ”’ PRO
    • πŸ”’ A.M. Watchlist
    • πŸ”’ Analyst Action
  • πŸ’Ό Business
  • πŸ“ˆ Investments
    • πŸ“ˆ Stocks
    • πŸ’° ETFs and Funds
    • πŸ’­ Market Commentary
    • πŸ“° Press Releases
    • πŸ“… Earnings Calendar
  • βš–οΈ Law
    • Laws
    • Politics
    • Intellectual Property
    • Attorneys & Law Firms Database
  • πŸ‘₯ People
    • ⚽ Athletes
    • πŸ’Ό Executives
    • 🌟 Celebrities
    • πŸ›’ Consumers
    • βš•οΈ Doctors
    • πŸ’Š Patients
  • πŸ’Š Health
  • πŸ“‡ Databases
    • πŸ“ˆ Stock Databases
    • πŸ’° Fund Databases
    • πŸ’Ό Service Providers Databases
    • 🏦 Marijuana Stock Brokers
    • πŸ’² Marijuana Cryptocurrencies

Β© 2018 - 2021 D.M.O. Holdings Corp.
DISCLAIMER: DMO Holdings Corp., which owns The Daily Marijuana Observerβ„’ (MJobserver.com), is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. DMO Holdings Corp., which owns MJobserver.com, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. DMO Holdings Corp. or its affiliates, which owns MJobserver.com, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two.

Login to your account below

Forgotten Password? Sign Up

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.